Advertisement

Topics

Novartis and Amgen halt clinical trials into #AlzheimersDisease drug after patients get worse http://bit.ly/30oxYls  #pharma #neuroscience #ClinicalTrialspic.twitter.com/LMxlBiGzf6

13:45 EDT 12 Jul 2019 | Pharmafile

Novartis and Amgen halt clinical trials into drug after patients get worse http://bit.ly/30oxYls 

Original Article: Novartis and Amgen halt clinical trials into #AlzheimersDisease drug after patients get worse http://bit.ly/30oxYls  #pharma #neuroscience #ClinicalTrialspic.twitter.com/LMxlBiGzf6

NEXT ARTICLE

More From BioPortfolio on "Novartis and Amgen halt clinical trials into #AlzheimersDisease drug after patients get worse http://bit.ly/30oxYls  #pharma #neuroscience #ClinicalTrialspic.twitter.com/LMxlBiGzf6"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...